SCHEMBL3764759

SCHEMBL3764759

CC(=CCCOCCCc1ccccc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
LSS P48449 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
FFAR1 O14842 1/20 0.42
NPC1 O15118 1/20 0.42
RECQL P46063 1/20 0.42
RAB9A P51151 1/20 0.42
HRH3 Q9Y5N1 1/20 0.41
S1PR1 P21453 2/20 0.41
IDO1 P14902 1/20 0.41
HDAC3 O15379 1/20 0.41
MAPK1 P28482 1/20 0.41
ADRA1A P35348 1/20 0.41
HDAC4 P56524 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3764753 1.00 LMNA (0.46) LMNALSSSMN1; SMN2MEN1KMT2A
SCHEMBL9565793 0.91 ALDH1A1 (0.43) SMN1; SMN2FFAR1NPC1RAB9AALDH1A1
SCHEMBL553141 0.89 LMNA (0.51) LMNALSSSMN1; SMN2MEN1KMT2A
SCHEMBL553139 0.89 LMNA (0.51) LMNALSSSMN1; SMN2MEN1KMT2A
SCHEMBL1574137 0.84 HDAC3 (0.48) SMN1; SMN2KMT2ANPC1RAB9AHDAC3
SCHEMBL4667862 0.84 HDAC3 (0.48) SMN1; SMN2KMT2ANPC1RAB9AHDAC3
SCHEMBL443151 0.84 HDAC3 (0.48) SMN1; SMN2KMT2ANPC1RAB9AHDAC3
SCHEMBL1572986 0.84 ALDH1A1 (0.45) LMNASMN1; SMN2ALDH1A1
SCHEMBL1572988 0.84 ALDH1A1 (0.45) LMNASMN1; SMN2ALDH1A1
SCHEMBL1122130 0.83 ALDH1A1 (0.47) LMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2535379-B1 Ink set and image forming method FUJIFILM CORP (JP) 2018-05-16 EP disclosed
EP-2902212-B1 IMAGE FORMATION METHOD FUJIFILM CORP (JP) 2017-09-06 EP disclosed
US-9517635-B2 Image forming method FUJIFILM CORPORATION (JP) 2016-12-13 US disclosed
EP-2902212-A1 IMAGE FORMATION METHOD FUJIFILM Corporation (JP) 2015-08-05 EP disclosed
US-20150166819-A1 IMAGE FORMING METHOD FUJIFILM CORPORATION (JP) 2015-06-18 US disclosed
US-20120320123-A1 INK SET AND IMAGE FORMING METHOD FUJIFILM CORPORATION (JP) 2012-12-20 US disclosed
EP-2535379-A1 Ink set and image forming method Fujifilm Corporation (JP) 2012-12-19 EP disclosed
US-7847888-B2 Liquid crystal display device including protective films having predetermined moisture permeability characteristics FUJIFILM CORPORATION (JP) 2010-12-07 US disclosed
US-20080218666-A1 Liquid crystal display device FUJIFILM CORPORATION (JP) 2008-09-11 US disclosed
US-7025816-B2 Anthraquinone dye and inkjet recording liquid KONICA MINOLTA HOLDINGS, INC. (JP) 2006-04-11 US disclosed
US-20050103226-A1 Anthraquinone dye and inkjet recording liquid KONICA MINOLTA HOLDINGS, INC. (JP) 2005-05-19 US disclosed
US-6340562-B1 HIGH SENSITIVITY, LOW FOG AND EXCELLENT PRESSURE RESISTANCE KONICA CORPORATION (JP) 2002-01-22 US disclosed
US-5455148-A Interfacial polymerization of acrylic acid and ester monomers and copolymer in aqueous and particle phases; curl resistance POLAROID CORPORATION (US) 1995-10-03 US disclosed
EP-0394791-B1 Photographic material having an antistatic layer AGFA GEVAERT AG (DE) 1995-09-06 EP disclosed
EP-0332165-A2 Silver halide color reversal photographic light-sensitive material Fuji Photo Film Co., Ltd. (JP) 1989-09-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050103226-A1 Anthraquinone dye and inkjet recording liquid MLLT3, GNPAT, IK LMNA 2299/4885LSS 2508/4885SMN1; SMN2 4059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.